Skip to main content
. 2022 Mar 10;66(4):e02192-21. doi: 10.1128/aac.02192-21

TABLE 5.

PK properties of compound 22 in mousee

Route of administration Dose (mg/kg) Cmax (μg/mL) Tmax (h) t1/2 (h) CLba (mL/min/kg) CLub (mL/min/kg) Vss (liters/kg) AUC0–∞c (h· μg/mL) Fd (%)
i.v. 2 3.7 14.3 210 5.1 2.37
p.o. 20 9.5 1.0 24.6 104
p.o. 100 47 2.8 343
p.o. 300 133 1.0 1271
p.o. 500 117 0.83 1435
a

Blood clearance.

b

Unbound clearance based on PPB = 93.2%.

c

Area under the curve.

d

Oral bioavailibility.

e

Tmax, time to maximum concentration of drug in serum; t1/2, half-life. Vss, volume at steady state.